ClinConnect ClinConnect Logo
Search / Trial NCT05025345

Vision Performance Evaluation of TECNIS EYHANCE™ With TECNIS SIMPLICITY™ Compared to TECNIS® 1-piece Intraocular Lenses

Launched by JOHNSON & JOHNSON SURGICAL VISION, INC. · Aug 26, 2021

Trial Information

Current as of June 10, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Minimum 22 years of age
  • Bilateral cataracts for which posterior chamber IOL implantation has been planned
  • Preoperative best corrected distance visual acuity (BCDVA) of 20/40 Snellen or worse with or without a glare source
  • Potential for postoperative best corrected visual acuity of 20/30 Snellen or better
  • * Corneal astigmatism parameters:
  • Normal corneal topography and no irregular corneal astigmatism
  • Postoperative astigmatism can be surgically managed to be less than 1 D in each eye
  • Clear intraocular media other than cataract in each eye
  • Availability, willingness, ability, and sufficient cognitive awareness to comply with examination procedures and study visits
  • Signed informed consent and HIPAA authorization or equivalent documentation necessary to comply with applicable privacy laws pertaining to medical treatment in the governing countries
  • Ability to understand and respond to a questionnaire in English
  • Exclusion Criteria:
  • Any conditions or circumstances, including those specified in the TECNIS Eyhance™ IOL Directions for Use, that, in the opinion of the investigator, may increase risk over benefit or result in an adverse event during the study.
  • Inability to focus or fixate for prolonged periods of time (e.g., due to strabismus, nystagmus, etc.)
  • Concurrent participation or participation within 60 days prior to preoperative visit in any other clinical trial
  • Desire for monovision correction

About Johnson & Johnson Surgical Vision, Inc.

Johnson & Johnson Surgical Vision, Inc. is a leading global company dedicated to advancing the field of ophthalmic surgery through innovative technologies and solutions. As a subsidiary of Johnson & Johnson, it specializes in the development and commercialization of products for cataract and refractive surgery, focusing on improving patient outcomes and enhancing surgical precision. With a commitment to research and development, the company collaborates with healthcare professionals to deliver cutting-edge medical devices and instrumentation that address the evolving needs of eye care providers and their patients.

Locations

Kingston, Pennsylvania, United States

Houston, Texas, United States

Sioux City, Iowa, United States

Sarasota, Florida, United States

Bakersfield, California, United States

San Antonio, Texas, United States

Saint Louis, Missouri, United States

Hurst, Texas, United States

Dallas, Texas, United States

Annapolis, Maryland, United States

San Antonio, Texas, United States

Houston, Texas, United States

Long Beach, California, United States

Cranberry Township, Pennsylvania, United States

San Antonio, Texas, United States

Patients applied

0 patients applied

Trial Officials

Johnson & Johnson Surgical Vision Clinical Trials

Study Director

Johnson & Johnson Surgical Vision

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials